相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia
Meena Kanduri et al.
BLOOD (2010)
Role of the nucleoplasmin 2 C-terminal domain in the formation of nucleolus-like bodies in mouse oocytes
Azusa Inoue et al.
FASEB JOURNAL (2010)
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
Lanlan Shen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A Genome-wide screen identifies frequently methylated genes in haematological and epithelial cancers
Thomas Dunwell et al.
MOLECULAR CANCER (2010)
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Ying Jiang et al.
BLOOD (2009)
PDLIM4, An Actin Binding Protein, Suppresses Prostate Cancer Cell Growth
Donkena Krishna Vanaja et al.
CANCER INVESTIGATION (2009)
Genome-wide screen of promoter methylation identifies novel markers in melanoma
Yasuo Koga et al.
GENOME RESEARCH (2009)
Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle
Yongjun Zhang et al.
JOURNAL OF CELL BIOLOGY (2009)
sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia
Melek Pehlivan et al.
LEUKEMIA RESEARCH (2009)
Methylation status of RASSF1A in patients with chronic myeloid leukemia
Antigoni Avramouli et al.
LEUKEMIA RESEARCH (2009)
Imatinib and beyond-exploring the full potential of targeted therapy for CML
Alfonso Quintas-Cardama et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
CpG island methylation profiling in human melanoma cell lines
Carmen S. Tellez et al.
MELANOMA RESEARCH (2009)
Treatment selection after imatinib resistance in chronic myeloid leukemia
Elias Jabbour et al.
TARGETED ONCOLOGY (2009)
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
Heike Kroeger et al.
BLOOD (2008)
Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia
S-Q Kuang et al.
LEUKEMIA (2008)
Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia
Jose Roman-Gomez et al.
LEUKEMIA RESEARCH (2008)
Identification of Novel Tumor Markers in Prostate, Colon and Breast Cancer by Unbiased Methylation Profiling
Woonbok Chung et al.
PLOS ONE (2008)
Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas
Yutaka Kondo et al.
HEPATOLOGY RESEARCH (2007)
High-throughput methylation profiling by MCA coupled to CpG island microarray
Marcos R. H. Estecio et al.
GENOME RESEARCH (2007)
LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability
Marcos R. H. Estecio et al.
PLOS ONE (2007)
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemia
Yasuhiro Oki et al.
CANCER (2007)
RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis
Yanis A. Boumber et al.
CANCER RESEARCH (2007)
Inactivation of HOXA genes by hypermethylation in myeloid and lymphoid malignancy is frequent and associated with poor prognosis
Gordon Strathdee et al.
CLINICAL CANCER RESEARCH (2007)
Correlation between CpG methylation profiles and hormone receptor status in breast cancers
Weiwei Feng et al.
BREAST CANCER RESEARCH (2007)
DNA methylation profiling of human chromosomes 6, 20 and 22
Florian Eckhardt et al.
NATURE GENETICS (2006)
Control of developmental regulator's by polycomb in human embryonic stem cells
TI Lee et al.
CELL (2006)
CpG island methylation and expression of the secreted frizzled-related protein gene family in chronic lymphocytic leukemia
TH Liu et al.
CANCER RESEARCH (2006)
被撤回的出版物: Promoter hypomethylation of the LINE-1 retrotransposable elements activates sense/antisense transcription and marks the progression of chronic myeloid leukemia (Retracted article. See vol. 32, pg. 804, 2013)
J Roman-Gomez et al.
ONCOGENE (2005)
Epigenetic changes in solid and hematopoietic tumors
M Toyota et al.
SEMINARS IN ONCOLOGY (2005)
Isolation and functional characterization of a novel organic solute carrier protein, hOSCP1
Y Kobayashi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate
JPJ Issa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A gene atlas of the mouse and human protein-encoding transcriptomes
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets
LJ Rush et al.
CANCER RESEARCH (2004)
A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements -: art. no. e38
AS Yang et al.
NUCLEIC ACIDS RESEARCH (2004)
DNA methylation in serum and tumors of cervical cancer patients
A Widschwendter et al.
CLINICAL CANCER RESEARCH (2004)
Cloning, expression, and mutation analysis of NOR1, a novel human gene down-regulated in HNE1 nasopharyngeal carcinoma cell line
XM Nie et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2003)
Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa
J Roman-Gomez et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
分享论文
